Depósito Digital de Documentos de la UAB Encontrados 4 registros  La búsqueda tardó 0.01 segundos. 
1.
15 p, 1.8 MB L-ferritin : One gene, five diseases; from hereditary hyperferritinemia to hypoferritinemia-report of new cases / Cadenas, Beatriz (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Fita-Torró, J. (BloodGenetics SL. Esplugues de Llobregat) ; Bermúdez-Cortés, M. (Pediatric OncoHematology Service. Clinic University Hospital Virgen de la Arrixaca. Instituto Murciano de Investigación Biosanitaria (IMIB)) ; Hernandez-Rodriguez, Inés (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Fuster, J.L. (Pediatric OncoHematology Service. Clinic University Hospital Virgen de la Arrixaca. Instituto Murciano de Investigación Biosanitaria (IMIB)) ; Llinares, M.E. (Pediatric OncoHematology Service. Clinic University Hospital Virgen de la Arrixaca. Instituto Murciano de Investigación Biosanitaria (IMIB)) ; Galera, A.M. (Pediatric OncoHematology Service. Clinic University Hospital Virgen de la Arrixaca. Instituto Murciano de Investigación Biosanitaria (IMIB)) ; Romero, J.L. (Biomedical Engineering Department. University of Texas at Austin) ; Pérez-Montero, S. (BloodGenetics SL. Esplugues de Llobregat) ; Tornador, C. (BloodGenetics SL. Esplugues de Llobregat) ; Sánchez-Fernández, Mayka (Institut Germans Trias i Pujol) ; Universitat Autònoma de Barcelona
Ferritin is a multimeric protein composed of light (L-ferritin) and heavy (H-ferritin) subunits that binds and stores iron inside the cell. A variety of mutations have been reported in the L-ferritin subunit gene (FTL gene) that cause the following five diseases: (1) hereditary hyperferritinemia with cataract syndrome (HHCS), (2) neuroferritinopathy, a subtype of neurodegeneration with brain iron accumulation (NBIA), (3) benign hyperferritinemia, (4) L-ferritin deficiency with autosomal dominant inheritance, and (5) L-ferritin deficiency with autosomal recessive inheritance. [...]
2019 - 10.3390/ph12010017
Pharmaceuticals, Vol. 12 Núm. 1 (2019) , p. 17  
2.
14 p, 1.5 MB Disposition of Phytocannabinoids, Their Acidic Precursors and Their Metabolites in Biological Matrices of Healthy Individuals Treated with Vaporized Medical Cannabis / Busardò, Francesco Paolo (Department of Excellence-Biomedical Sciences and Public Health, Università Politecnica delle Marche, 60121 Ancona, Italy) ; Pérez-Acevedo, Ana Pilar (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Pacifici, Roberta (National Centre on Addiction and Doping, Istituto Superiore di Sanità, 00161 Rome, Italy) ; Mannocchi, Giulio (School of Law, University of Camerino, 62032 Camerino, Italy) ; Gottardi, Massimo (Comedical S.Rl, 38123 Trento, Italy) ; Papaseit, Esther (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Pérez-Mañá, Clara (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Martin, Soraya (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Poyatos, Lourdes (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Pichini, Simona (National Centre on Addiction and Doping, Istituto Superiore di Sanità, 00161 Rome, Italy) ; Farré Albaladejo, Magí (Universitat Autònoma de Barcelona. Departament de Farmacologia, de Terapèutica i de Toxicologia)
Inhalation by vaporization is a useful application mode for medical cannabis. In this study, we present the disposition of Δ9-tetrahydrocannabinol (THC), cannabidiol (CBD), their acidic precursors, and their metabolites in serum, oral fluid, and urine together with the acute pharmacological effects in 14 healthy individuals treated with vaporized medical cannabis. [...]
2021 - 10.3390/ph14010059
Pharmaceuticals, Vol. 14 (january 2021)  
3.
26 p, 542.7 KB Stem Cell Therapy : A New Treatment for Burns? / Arno, Anna (Hospital Universitari Vall d'Hebron) ; Smith, Alexandra H. (Ross Tilley Burn Centre, Sunnybrook Health Sciences Centre, University of Toronto, 2075 Bayview Avenue, Toronto, Ontario M4N 3M5, Canada) ; Blit, Patrick H. (Ross Tilley Burn Centre, Sunnybrook Health Sciences Centre, University of Toronto, 2075 Bayview Avenue, Toronto, Ontario M4N 3M5, Canada) ; Shehab, Mohammed Al (Ross Tilley Burn Centre, Sunnybrook Health Sciences Centre, University of Toronto, 2075 Bayview Avenue, Toronto, Ontario M4N 3M5, Canada) ; Gauglitz, Gerd G. (Department of Dermatology and Allergology, Ludwig Maximilians University, Geschwister-Scholl-Platz 1, 80539, Munich, Germany) ; Jeschke, Marc G. (Ross Tilley Burn Centre, Sunnybrook Health Sciences Centre, University of Toronto, 2075 Bayview Avenue, Toronto, Ontario M4N 3M5, Canada) ; Universitat Autònoma de Barcelona
Stem cell therapy has emerged as a promising new approach in almost every medicine specialty. This vast, heterogeneous family of cells are now both naturally (embryonic and adult stem cells) or artificially obtained (induced pluripotent stem cells or iPSCs) and their fates have become increasingly controllable, thanks to ongoing research in this passionate new field. [...]
2011 - 10.3390/ph4101355
Pharmaceuticals, Vol. 4 (october 2011) , p. 1355-1380  
4.
18 p, 1.8 MB Targeting protein kinase CK2 : evaluationg CX-4945 potential for GL261 glioblastoma therapy in immunocompetent mice / Ferrer-Font, Laura (Institut de Biotecnologia i de Biomedicina "Vicent Villar Palasí") ; Villamañán de Santiago, Lucía (Universitat Autònoma de Barcelona. Departament de Bioquímica i Biologia Molecular) ; Arias-Ramos, Nuria (Universitat Autònoma de Barcelona. Departament de Bioquímica i Biologia Molecular) ; Vilardell Vilà, Jordi (Università degli studi di Padova. Dipartimento di Scienze Biomediche) ; Plana i Coll, Maria (Universitat Autònoma de Barcelona. Departament de Bioquímica i Biologia Molecular) ; Ruzzene, Maria (Università degli studi di Padova. Dipartimento di Scienze Biomediche) ; Pinna, Lorenzo A. (Università degli studi di Padova. Dipartimento di Scienze Biomediche) ; Itarte, Emilio (Universitat Autònoma de Barcelona. Departament de Bioquímica i Biologia Molecular) ; Arús i Caraltó, Carles (Universitat Autònoma de Barcelona. Departament de Bioquímica i Biologia Molecular) ; Candiota Silveira, Ana Paula (Universitat Autònoma de Barcelona. Departament de Bioquímica i Biologia Molecular)
Glioblastoma (GBM) causes poor survival in patients even with aggressive treatment. Temozolomide (TMZ) is the standard chemotherapeutic choice for GBM treatment but resistance always ensues. Protein kinase CK2 (CK2) contributes to tumour development and proliferation in cancer, and it is overexpressed in human GBM. [...]
2017 - 10.3390/ph10010024
Pharmaceuticals, Vol. 10 Núm. 1 (2017) , p. art 24
2 documentos

¿Le interesa recibir alertas sobre nuevos resultados de esta búsqueda?
Defina una alerta personal vía correo electrónico o subscríbase al canal RSS.